about
Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinibIdentification of a novel human ankyrin-repeated protein homologous to CARP.Primary CNS CCND1/MYC-Positive Double-Hit B-Cell Lymphoma: A Case Report and Review of the Literature.KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomasCarp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomasKLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue onlyDetection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphomaAllelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes.Frequent inactivation of A20 in B-cell lymphomas.A case of synchronous bilateral lung cancers: EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ (the former bronchioloalveolar carcinoma) in the left lung.Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutationAbsolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphomaA rational diagnostic algorithm for the identification of ALK rearrangement in lung cancer: a comprehensive study of surgically treated Japanese patients.Cytophagic histiocytic panniculitis with fatal haemophagocytic lymphohistiocytosis in a paediatric patient with perforin gene mutationNUT midline carcinoma mimicking a germ cell tumor: a case reportIdentification of cell-type-specific mutations in nodal T-cell lymphomas.Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung CancerInfusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in JapanExtranodal NK/T-cell lymphoma: diagnosis and treatment cues.Radiation therapy for localized duodenal low-grade follicular lymphoma.Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocationsInflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation.Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acquired MET amplification after erlotinib therapy.Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature.ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.Establishment and characterization of a clear cell odontogenic carcinoma cell line with EWSR1-ATF1 fusion gene.Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers.BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.
P50
Q27851438-9218585D-EB37-4EAA-802E-763E312E1084Q27851453-88018BDA-235B-430A-B287-9B7473E9A5DFQ27851590-B0F1E44A-4780-41DA-9F7C-47831FC6B2CAQ27851704-DC563DC9-3471-4E0B-9F74-335E41204686Q27853072-D9D0BDEE-863D-478F-BC99-2C6F30D4F830Q30687802-B31E14E1-05A0-4915-B307-24C6A9F3C9CAQ30790383-E1D2E009-8F8A-4A40-8C1E-B26A47E9EAE2Q33433329-FC41A818-B5AE-476D-A168-9C0D1727F50BQ33480141-E1F5B095-1604-448A-BB63-D74FEC65F755Q33701858-37521476-9DD9-47BB-BE3A-73D9A18777ACQ33779534-60891084-FA10-4025-A5FA-EC652BE82CA3Q34127618-2E72A71E-6631-4717-8834-78F244414919Q34162787-F69943BE-089D-47F5-9EDF-113BA0571441Q34332071-729FD602-A6C5-4A66-A7D7-E9CCD1D84AE3Q34332888-D874DCC8-47BC-4F0C-B490-A37B99A3F734Q34435074-CC519B54-9EE1-42B5-A4EB-775FC80E7FA2Q34536679-0CC97AA4-424C-4B2D-BF37-CEEEC229E0FCQ34607223-23630EE0-B3F6-4B52-B539-9808F808C0A6Q34686818-67F1DFC7-CAD8-4D1E-BC89-A59B774F356AQ34743127-587779F7-6D04-4054-82A0-FC0E258714ACQ34798062-1DC537F8-8140-4959-A5A7-FF435D851DD5Q34924658-CB0A086F-57E3-4439-B9B8-CFFED1FA5E03Q36054912-487391C5-104F-4BE7-850E-FD0991B2E8E2Q36195509-AFB4B15B-EFC4-4F58-B7AB-3654195F748BQ36269008-A5915343-3258-46C9-888A-1117177F071AQ36384499-DC511F8B-F8B3-4061-AF88-5B2E0081EB89Q36538788-DBBE2B8D-9094-416A-9A7D-6B26D1013B40Q36830105-6B1A6E46-3469-4400-B4E6-9757B2D92FADQ37088148-7C87975F-F04C-4206-BD61-618C0FA9CA9AQ37152169-4DB44599-62A2-460D-8419-535CD0AA6DC1Q37187172-138EDB1C-8BD3-4A14-B32E-97A75D0DF1C0Q37246742-E0A2D405-8DA6-430D-A076-460B463E416CQ37362414-A448BE92-8D8D-4007-87D6-DA5D0F840172Q37478909-DC524510-B029-4E3A-84E1-BCDF2FFFE088Q37660829-E34C5B72-0EF4-456E-9260-1F3D37E7ABE8Q38120989-5CF9681D-72FB-4F99-93B0-97C7030729CFQ38701797-935BAE53-128D-4F51-8925-4FAD4F85A2FCQ38701816-19D181F0-67AB-4659-A11F-EA6E87337FCFQ38765494-EF7D7768-3CAF-4B54-B4D9-DC2A19FED72FQ38776124-CB9E9116-3D18-4C79-9E13-32C424022ED7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kengo Takeuchi
@ast
Kengo Takeuchi
@en
Kengo Takeuchi
@es
Kengo Takeuchi
@nl
Kengo Takeuchi
@sl
type
label
Kengo Takeuchi
@ast
Kengo Takeuchi
@en
Kengo Takeuchi
@es
Kengo Takeuchi
@nl
Kengo Takeuchi
@sl
prefLabel
Kengo Takeuchi
@ast
Kengo Takeuchi
@en
Kengo Takeuchi
@es
Kengo Takeuchi
@nl
Kengo Takeuchi
@sl
P1053
C-3614-2008
P106
P1153
12041787000
P21
P31
P3829
P496
0000-0002-1599-5800
P569
2000-01-01T00:00:00Z